TX-WEA
12.7.2021 14:34:06 CEST | Business Wire | Press release
The Women’s Entrepreneurship Accelerator (WEA), a leading driver for increased women’s economic participation, joined the Generation Equality Forum in Paris (June 30-July 2) through the “Drivers of Change” Program. 26 years after the Beijing Declaration, the Generation Equality Forum, convened by UN Women and co-hosted by the governments of Mexico and France, is the “most critical moment in a generation to invest in gender equality and accelerate momentum for women’s safety, leadership and economic opportunity1 . 50,000 people virtually engaged in the Forum which gathered 1,000 commitment-makers, recorded $40 billion of investments for gender equality in support of a 5-year plan to act for equal across 7 areas of action.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210712005178/en/
On July 2, the Accelerator hosted a panel titled “Building a Transformative Strategy for Gender-Responsive Procurement,” aiming at creating awareness of the disproportionately complex and interconnected barriers on women’s entrepreneurship and promoting gender-responsive procurement strategies. Globally, 1 in 3 businesses are owned by women2 , yet women win only 1% of the procurement spend of governments and large corporations3 . Speakers shared insights and concrete advice substantiated by their own journey on how to implement inclusive procurement strategies.
Launched in 2019, the Women’s Entrepreneurship Accelerator is a multi-partner initiative designed to inspire, educate, and empower women entrepreneurs around the world. The mission of the Accelerator is to eliminate barriers for women entrepreneurs through four Pathways of Empowerment: Education, Funding, Advocacy, and Participation. With no qualifying barriers to participate, the global initiative, incepted by Mary Kay Inc., is a strategic collaboration developed in consultation with five United Nations agencies.
“We believe that gender-responsive procurement can make an enormous impact which accelerates the inclusion of women-owned businesses throughout the supply chain,” said Julia Simon, Chief Legal & Diversity Officer at Mary Kay Inc. “The Accelerator encourages the public and private sectors to make inclusive procurement a priority and drive the systemic change that women need. Supporting women entrepreneurs is critical for sustainable growth.”
Simon was one of the panelists featured during Gender Equality Forum’s Gender-Responsive Procurement discussion. She was joined by Elizabeth Vazquez, CEO and Co-Founder of WEConnect International and Jamila Belabidi, Purchases Director, Global Women Economic Empowerment & Global Innovation, Procter & Gamble. Sonia Dridi, journalist & Washington DC correspondent for France 24 and Europe 1, moderated the session.
“It’s a $93 trillion global economy, but women continue to be invisible as suppliers of products and services in our global value chains,” said Vazquez. “This massive market failure must be corrected with urgency so that more women can contribute to and benefit from inclusive economic prosperity and job creation in support of SDG5.”
“At P&G, our focus on gender equality is foundational and integrated into our business, as such, we are committed to spending $10 billion with women-owned and women-led businesses by 2025,” said Jamila Belabidi, Purchases Director, Global Women’s Economic Empowerment & Global Innovation at Procter & Gamble.
At the event, WEA also joined four of the Generation Equality Action Coalitions through policy, programmatic, and advocacy commitments: Economic Justice and Rights; Feminist Action for Climate Justice; Technology and Innovation for Gender Equality; and Feminist Movements and Leadership. The Accelerator also committed to empower 5 million women by the end of 2030 by alleviating the main economic and social roadblocks faced by women entrepreneurs.
The Accelerator’s participation in the Generation Equality Forum Action Coalitions is just the latest in a series of steps taken by the organization to raise awareness of women’s equality post COVID:
-
On March 16, 2021, Deborah Gibbins, Mary Kay’s Chief Operations Officer, joined the UN Global Compact Target Gender Equality
meeting on behalf of the Accelerator. Gibbins highlighted data freshly released by the World Bank revealing that on average across the world, women have three quarters of the legal rights of men. She challenged companies to take a stand against legal discriminations and advocate for reform to close the gaps so that women can achieve their full potential. The event brought together over 5,000 people from the business sector, the United Nations, member states, and civil society organizations from over 100 countries, with 75% of the participants representing the private sector.
- On March 24, 2021, on the sidelines of the Commission on the Status of Women (CSW65), the Women’s Empowerment Accelerator hosted a panel titled: “Women Leading Economic Recovery Through Entrepreneurship,” with five UN agency partners. The collective highlighted the need for public-private sector partnerships to help shape an enabling ecosystem for women entrepreneurs.
- On June 15-16, 2021, at the UN Global Compact Leaders Summit , Gibbins spoke at the “Women in Sustainability: Innovating in a Man’s World” main stage session advocating for women entrepreneurs as the role models needed by the economy and the society and emphasizing the critical mission of the Accelerator: “Women entrepreneurship will play a key role in the successful pandemic recovery. This is why the mission of the Women’s Entrepreneurship Accelerator is so timely. And, this is why women entrepreneurs need a framework of this magnitude,” said Gibbins. The annual Summit convened virtually more than 25,000 leaders from business, government, the UN, and civil society, to take stock of the state of progress and to drive collective action towards alleviating climate crisis, global pandemic, economic disparities, and social inequalities.
About the Women’s Entrepreneurship Accelerator
The Women’s Entrepreneurship Accelerator is a multi-partner initiative designed to inspire, educate, and empower women entrepreneurs around the world. The mission of the Accelerator is to eliminate barriers for women entrepreneurs around the world through Four Pathways of Empowerment: Education, Funding, Advocacy, and Participation. With no qualifying barriers to participate, the global initiative incepted by Mary Kay Inc. is a strategic collaboration developed in consultation with five United Nations agencies: UN Women, International Labour Organization (ILO), International Trade Centre (ITC), UN Global Compact (UNGC), and the United Nations Development Programme (UNDP). The Accelerator aims to economically empower 5 million women by the end of 2030. Learn more at https://www.we-accelerate.com/
1
https://forum.generationequality.org/home
2
World Bank (2020). Enterprise Surveys, World Bank Gender Data Portal
cited by World Bank Blogs (2020) Women entrepreneurs needed – stat!
3
Vazquez and Sherman (2014). Cited by UN Women (2017) The Power of Procurement: How to source from women-owned businesses
.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210712005178/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
